Bristol-Myers Squibb: SEC Spurns Bristol Myers Bid to Stop Voting on Anti-DEI Plan
The SEC has rebuffed a Bristol-Myers Squibb Co. campaign against a shareholder proposal urging it to scrap its diversity, equity, and inclusion policies.
Read full article »
Bristol Myers Squibb is a New Jersey-based biopharmaceutical company that discovers, develops and commercializes medicines for patients with serious diseases.
Read more